President Trump signed into law a funding package for the Food and Drug Administration that also takes steps to lower drug prices.
The president signed into law the FDA Reauthorization Act of 2017 on Friday. It reauthorizes a program in which drug and device makers pay the FDA a fee for every new product application, and the agency uses that money to hire more people and speed up approvals.
In-depth coverageas the midterms
take shape.
Follow the latest midterm news, analysis, and expert perspectives with unlimited access.
See Subscription Options
Already a member? Log in
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.